文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

负载超顺磁性氧化铁纳米颗粒的人 T 细胞保持抗原特异性 TCR 功能。

Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality.

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Erlangen, Germany.

Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.

出版信息

Front Immunol. 2023 Aug 17;14:1223695. doi: 10.3389/fimmu.2023.1223695. eCollection 2023.


DOI:10.3389/fimmu.2023.1223695
PMID:37662937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10470061/
Abstract

BACKGROUND: Immunotherapy of cancer is an emerging field with the potential to improve long-term survival. Thus far, adoptive transfer of tumor-specific T cells represents an effective treatment option for tumors of the hematological system such as lymphoma, leukemia or myeloma. However, in solid tumors, treatment efficacy is low owing to the immunosuppressive microenvironment, on-target/off-tumor toxicity, limited extravasation out of the blood vessel, or ineffective trafficking of T cells into the tumor region. Superparamagnetic iron oxide nanoparticles (SPIONs) can make cells magnetically controllable for the site-specific enrichment. METHODS: In this study, we investigated the influence of SPION-loading on primary human T cells for the magnetically targeted adoptive T cell therapy. For this, we analyzed cellular mechanics and the T cell response after stimulation via an exogenous T cell receptor (TCR) specific for the melanoma antigen MelanA or the endogenous TCR specific for the cytomegalovirus antigen pp65 and compared them to T cells that had not received SPIONs. RESULTS: SPION-loading of human T cells showed no influence on cellular mechanics, therefore retaining their ability to deform to external pressure. Additionally, SPION-loading did not impair the T cell proliferation, expression of activation markers, cytokine secretion, and tumor cell killing after antigen-specific activation mediated by the TCR. CONCLUSION: In summary, we demonstrated that SPION-loading of T cells did not affect cellular mechanics or the functionality of the endogenous or an exogenous TCR, which allows future approaches using SPIONs for the magnetically enrichment of T cells in solid tumors.

摘要

背景:癌症的免疫疗法是一个新兴领域,具有提高长期生存率的潜力。到目前为止,肿瘤特异性 T 细胞的过继转移代表了一种针对血液系统肿瘤(如淋巴瘤、白血病或骨髓瘤)的有效治疗选择。然而,在实体肿瘤中,由于免疫抑制微环境、针对目标/脱靶毒性、有限的血管外渗或 T 细胞向肿瘤区域的有效转运,治疗效果较低。超顺磁氧化铁纳米颗粒(SPIONs)可使细胞具有磁性可控性,从而实现特异性富集。

方法:在这项研究中,我们研究了 SPION 加载对原代人 T 细胞用于磁性靶向过继 T 细胞治疗的影响。为此,我们分析了细胞力学和刺激后 T 细胞的反应,这些刺激通过针对黑色素瘤抗原 MelanA 的外源性 T 细胞受体(TCR)或针对巨细胞病毒抗原 pp65 的内源性 TCR 进行特异性刺激,并将其与未接受 SPION 的 T 细胞进行比较。

结果:SPION 加载对人 T 细胞的细胞力学没有影响,因此保留了它们对外界压力变形的能力。此外,SPION 加载不会损害 T 细胞增殖、激活标志物表达、细胞因子分泌和抗原特异性激活介导的肿瘤细胞杀伤作用。

结论:总之,我们证明了 T 细胞的 SPION 加载不会影响细胞力学或内源性或外源性 TCR 的功能,这允许未来使用 SPION 来磁性富集实体瘤中的 T 细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/681bd69751e9/fimmu-14-1223695-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/0f33d23a5ad5/fimmu-14-1223695-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/045562d6ad5f/fimmu-14-1223695-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/204d2c4c9d3c/fimmu-14-1223695-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/bd4823bbdcf9/fimmu-14-1223695-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/acff7d339246/fimmu-14-1223695-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/af24a2aae9e8/fimmu-14-1223695-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/681bd69751e9/fimmu-14-1223695-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/0f33d23a5ad5/fimmu-14-1223695-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/045562d6ad5f/fimmu-14-1223695-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/204d2c4c9d3c/fimmu-14-1223695-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/bd4823bbdcf9/fimmu-14-1223695-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/acff7d339246/fimmu-14-1223695-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/af24a2aae9e8/fimmu-14-1223695-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d588/10470061/681bd69751e9/fimmu-14-1223695-g007.jpg

相似文献

[1]
Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality.

Front Immunol. 2023

[2]
Loading of Primary Human T Lymphocytes with Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Does Not Impair Their Activation after Polyclonal Stimulation.

Cells. 2020-2-1

[3]
Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation.

Cancers (Basel). 2021-8-17

[4]
Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy.

Int J Nanomedicine. 2019-10-24

[5]
Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment.

ACS Nano. 2024-4-30

[6]
nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma.

Theranostics. 2023

[7]
Cell Viability and Immunogenic Function of T Cells Loaded with Nanoparticles for Spatial Guidance in Magnetic Fields.

Methods Mol Biol. 2023

[8]
Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.

Nanotoxicology. 2016

[9]
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.

Blood. 2017-1-4

[10]
Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.

ACS Appl Mater Interfaces. 2017-11-1

引用本文的文献

[1]
Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.

Mol Cancer. 2025-9-1

[2]
[Current aspects of nanoparticle-based therapy in head and neck cancer].

HNO. 2025-5-19

[3]
Loading monocytes with magnetic nanoparticles enables their magnetic control without toxicity.

Front Bioeng Biotechnol. 2025-1-8

[4]
Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.

MedComm (2020). 2025-1-5

[5]
Personalized nanovaccines for treating solid cancer metastases.

J Hematol Oncol. 2024-11-28

[6]
Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions.

Pharmaceuticals (Basel). 2024-6-25

[7]
Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.

Int J Mol Sci. 2023-12-29

本文引用的文献

[1]
In Vitro Setup for Determination of Nanoparticle-Mediated Magnetic Cell and Drug Accumulation in Tumor Spheroids under Flow Conditions.

Cancers (Basel). 2022-12-3

[2]
CAR T cell therapy in solid tumors: A review of current clinical trials.

EJHaem. 2021-12-7

[3]
TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines.

Nat Methods. 2022-7

[4]
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets.

J Hematol Oncol. 2022-5-18

[5]
The solid tumor microenvironment-Breaking the barrier for T cells: How the solid tumor microenvironment influences T cells: How the solid tumor microenvironment influences T cells.

Bioessays. 2022-6

[6]
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects.

Front Immunol. 2022

[7]
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival.

J Immunother Cancer. 2022-2

[8]
In vivo imaging of nanoparticle-labeled CAR T cells.

Proc Natl Acad Sci U S A. 2022-2-8

[9]
Cancer statistics, 2022.

CA Cancer J Clin. 2022-1

[10]
Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation.

Cancers (Basel). 2021-8-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索